(Q38029406)

27 August 2017

title

Analytical challenges in the detection of peptide hormones for anti-doping purposes (English)

1 reference

27 August 2017

4

Mario Thevis

1 reference

27 August 2017

2

David J Handelsman

1 reference

27 August 2017

Osquel Barroso

1

1 reference

27 August 2017

Christian Strasburger

series ordinal

3

1 reference

27 August 2017

publication date

1 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

4

1 reference

27 August 2017

issue

13

1 reference

27 August 2017

page(s)

1577-1590

1 reference

Hormone abuse in sports: the antidoping perspective

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

21 January 2018

Growth hormone isoforms

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

A high-throughput test to detect C.E.R.A. doping in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

The athlete's biological passport and indirect markers of blood doping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Characterization of N- and O-glycopeptides of recombinant human erythropoietins as potential biomarkers for doping analysis by means of microscale sample purification combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Mass spectrometric determination of insulins and their degradation products in sports drug testing

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Mass spectrometry-based analysis of IGF-1 and hGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Quantification of growth hormone in serum by isotope dilution mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Can glycans unveil the origin of glycoprotein hormones? - human chorionic gonadotrophin as an example -.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

An introduction to mass spectrometry based proteomics-detection and characterization of gonadotropins and related molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Simultaneous quantification and qualification of synacthen in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Growth hormone: its measurement and the need for assay harmonization

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using various fresh and stored serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Aptamer-based multiplexed proteomic technology for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Procedures for monitoring recombinant erythropoietin and analogues in doping control

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Recent developments in doping testing for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Clinical review: The rationale for banning human chorionic gonadotropin and estrogen blockers in sport

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Pulsatile intravenous infusion of recombinant human luteinizing hormone under acute gonadotropin-releasing hormone receptor blockade reconstitutes testosterone secretion in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Gonadotropins in doping: pharmacological basis and detection of illicit use.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Loss of human chorionic gonadotropin in urine during storage at -20°C.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Pharmacokinetics of gonadotropin-releasing hormone and its analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Use of gonadotrophin-releasing hormone agonists to trigger ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Optimal starting time for flutamide to prevent disease flare in prostate cancer patients treated with a gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the determination of leuprolide in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Delivery and stability of LHRH and Nafarelin in human skin: the effect of constant/pulsed iontophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Detection of GH abuse in sport: Past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Growth hormone doping in sports: a critical review of use and detection strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Growth hormone isoforms release in response to physiological and pharmacological stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Comparison of [125I]Somatomedin A and [125I]Somatomedin C Radioreceptor Assays for Somatomedin Peptide Content in Whole and Acid-Chromatographed Plasma*

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Massspectrometrical analysis of recombinant human growth hormone Norditropin reveals amino acid exchange at M14_V14 rhGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Quantitative mass spectrometric immunoassay of insulin like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Desmopresssin and hemodilution: implications in doping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

OMICS-strategies and methods in the fight against doping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Isotope dilution strategies for absolute quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Stable-isotope dilution LC–MS for quantitative biomarker analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

Labelled Antibodies and Immunological Assay Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.12.128

21 January 2018

Identifiers

DOI

10.4155/BIO.12.128

1 reference

27 August 2017

1 reference